These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36510340)
1. Association of AXIN1 rs12921862 C/A and rs1805105 G/A and CTSB rs12898 G/A polymorphisms with papillary thyroid carcinoma: A case-control study. Saljooghi S; Heidari Z; Saravani M; Rezaei M; Salimi S J Clin Lab Anal; 2023 Jan; 37(1):e24804. PubMed ID: 36510340 [TBL] [Abstract][Full Text] [Related]
2. Significant Associations between AXIN1 rs1805105, rs12921862, rs370681 Haplotypes and Variant Genotypes of AXIN2 rs2240308 with Risk of Congenital Heart Defects. Crauciuc GA; Iancu M; Olah P; Tripon F; Anciuc M; Gozar L; Togănel R; Bănescu C Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33096676 [TBL] [Abstract][Full Text] [Related]
3. Association Between Li K; Zhong Y; Peng Y; Zhou B; Wang Y; Li Q; Zhang Y; Song H; Rao L DNA Cell Biol; 2019 May; 38(5):436-442. PubMed ID: 30810360 [TBL] [Abstract][Full Text] [Related]
4. Association between polymorphisms in AXIN1 gene and atrial septal defect. Pu Y; Chen P; Zhou B; Wang Y; Song Y; Peng Y; Rao L; Zhang L Biomarkers; 2014 Dec; 19(8):674-8. PubMed ID: 25355064 [TBL] [Abstract][Full Text] [Related]
5. Genetic association of polymorphisms in AXIN1 gene with clear cell renal cell carcinoma in a Chinese population. Pu Y; Mi X; Chen P; Zhou B; Zhang P; Wang Y; Song Y; Zhang L Biomark Med; 2017 Nov; 11(11):947-955. PubMed ID: 29053018 [TBL] [Abstract][Full Text] [Related]
6. Association between Li Q; Zhang P; Wang Y; Zhang Y; Li K; Song Y; Su M; Zhou B; Zhang L Dis Markers; 2019; 2019():3949343. PubMed ID: 31143301 [TBL] [Abstract][Full Text] [Related]
7. Role of MDM2 309T>G (rs2279744) and I/D (rs3730485) polymorphisms and haplotypes in risk of papillary thyroid carcinoma, tumor stage, tumor size, and early onset of tumor: A case control study. Maruei-Milan R; Heidari Z; Salimi S J Cell Physiol; 2019 Aug; 234(8):12934-12940. PubMed ID: 30548972 [TBL] [Abstract][Full Text] [Related]
8. Investigating AXIN1 gene polymorphisms in Turkish children with cryptorchidism: A pilot study. Doğan G; Yılmaz A; İpek H; Metin M; Peltek Kendirci HN; Afşarlar ÇE J Pediatr Urol; 2024 Aug; 20(4):748.e1-748.e7. PubMed ID: 38880668 [TBL] [Abstract][Full Text] [Related]
9. Association between Zhang Y; Wang Y; Huang X; Li Q; Li K; You D; Song Y; Su M; Zhou B; Wang W Biomark Med; 2019 Apr; 13(6):445-455. PubMed ID: 30929455 [No Abstract] [Full Text] [Related]
10. The variations in the AXIN1 gene and susceptibility to cryptorchidism. Zhou B; Tang T; Chen P; Pu Y; Ma M; Zhang D; Li L; Zhang P; Song Y; Zhang L J Pediatr Urol; 2015 Jun; 11(3):132.e1-5. PubMed ID: 25802106 [TBL] [Abstract][Full Text] [Related]
11. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features. Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498 [TBL] [Abstract][Full Text] [Related]
12. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility. Dong G; Zhang R; Xu J; Guo Y Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma. Bingül İ; Vural P; Doğru-Abbasoğlu S; Çil E; Uysal M J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 27925342 [TBL] [Abstract][Full Text] [Related]
14. The effect of CASP3 rs4647610 and rs4647602 polymorphisms on tumour size and cancer stage in papillary thyroid carcinoma. Heidari Z; Eskandari M; Aryan A; Rostamzad F; Salimi S Br J Biomed Sci; 2020 Jul; 77(3):129-134. PubMed ID: 32151194 [TBL] [Abstract][Full Text] [Related]
15. Association between Genetic Polymorphisms in microRNA Machinery Genes and Risk of Papillary Thyroid Carcinoma. Mohammadpour-Gharehbagh A; Heidari Z; Eskandari M; Aryan A; Salimi S Pathol Oncol Res; 2020 Apr; 26(2):1235-1241. PubMed ID: 31250375 [TBL] [Abstract][Full Text] [Related]
16. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population. Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075 [TBL] [Abstract][Full Text] [Related]
17. Genetic Polymorphisms in APC, DVL2, and AXIN1 Are Associated with Susceptibility, Advanced TNM Stage or Tumor Location in Colorectal Cancer. Rosales-Reynoso MA; Saucedo-Sariñana AM; Contreras-Díaz KB; Márquez-González RM; Barros-Núñez P; Pineda-Razo TD; Marin-Contreras ME; Durán-Anguiano Ó; Gallegos-Arreola MP; Flores-Martínez SE; Sánchez-Corona J Tohoku J Exp Med; 2019 Nov; 249(3):173-183. PubMed ID: 31723073 [TBL] [Abstract][Full Text] [Related]
18. Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development. Maruei-Milan R; Saravani M; Heidari Z; Asadi-Tarani M; Salimi S IUBMB Life; 2020 Dec; 72(12):2601-2610. PubMed ID: 33107190 [TBL] [Abstract][Full Text] [Related]
19. Risk genetic polymorphism and haplotype associated with papillary thyroid cancer and their relation to associated diseases in Slovak population. Duffek M; Skerenova M; Halasova E; Sarlinova M; Dzian A; Repiska V; Dobrovodsky A; Mistuna D; Bernadic M; Matakova T Bratisl Lek Listy; 2022; 123(7):475-48. PubMed ID: 35907052 [TBL] [Abstract][Full Text] [Related]
20. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population. Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]